Our goal is to cure prostate cancer, to maximise quality of life for patients, and to advance state-of-the-art cancer treatment.
Does a Man's Estrogen Level Impact His Risk of Prostate Cancer?
A high level of one type of estrogen in a man’s body might increase his risk of developing prostate cancer. That is one surprising conclusion from a new study which also offers another novel finding – that high levels of the estrogen considered fuel for breast cancer might offer a protective benefit against prostate cancer. Details of the research will be presented at the AACR 101st Annual Meeting 2010.
U.S. Cancer Screening Trial Shows No Early Mortality Benefit from Annual Prostate Cancer Screening
Six annual screenings for prostate cancer led to more diagnoses of the disease, but no fewer prostate cancer deaths, according to a major new report from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. The Lombardi Comprehensive Cancer Center at Georgetown University Medical Center is one of the 10 sites that enrolled participants onto this trial. The PLCO was designed to provide answers about the effectiveness of prostate cancer screening.